|
GB9422096D0
(en)
*
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
|
US5811102A
(en)
*
|
1995-06-07 |
1998-09-22 |
National Research Council Of Canada |
Modified meningococcal polysaccharide conjugate vaccines
|
|
ES2166097T5
(es)
*
|
1996-08-27 |
2007-03-16 |
Novartis Vaccines And Diagnostics, Inc. |
Glicoconjugados de neisseria meningitidis de serogrupo b y procedimientos para usarlos.
|
|
US6048527A
(en)
|
1996-08-27 |
2000-04-11 |
Chiron Corporation |
Antibodies that define unique Meningococcal B epitopes and vaccine compositions
|
|
CA2301942C
(en)
|
1997-08-27 |
2011-05-31 |
Chiron Corporation |
Molecular mimetics of meningococcal b epitopes
|
|
GB9823835D0
(en)
*
|
1998-10-30 |
1998-12-23 |
Univ London |
Component for vaccine
|
|
CA2353072A1
(en)
*
|
1998-12-14 |
2000-06-22 |
Palatin Technologies, Inc. |
Metallopeptide combinatorial libraries and applications
|
|
US7033748B2
(en)
*
|
1999-08-06 |
2006-04-25 |
Ivigene Corporation |
Identification of microbial polynucleotides expressed during infection of a host
|
|
ATE414172T1
(de)
|
1999-08-06 |
2008-11-15 |
Oragenics Inc |
Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden
|
|
US7049398B1
(en)
*
|
1999-08-12 |
2006-05-23 |
Palatin Technologies, Inc. |
Melanocortin metallopeptide constructs, combinatorial libraries and applications
|
|
US6838553B1
(en)
*
|
1999-10-05 |
2005-01-04 |
Academia Sinica |
Peptide repeat immunogens
|
|
US7189405B1
(en)
*
|
1999-10-29 |
2007-03-13 |
Rice Peter A |
Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
|
|
WO2001036006A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Palatin Technologies, Inc. |
Opioid metallopeptide compositions and methods
|
|
PT2289545T
(pt)
*
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
|
GB0024200D0
(en)
*
|
2000-10-03 |
2000-11-15 |
Smithkline Beecham Sa |
Component vaccine
|
|
US7385025B2
(en)
|
2000-12-19 |
2008-06-10 |
Palatin Technologies, Inc. |
Metallopeptide compounds
|
|
AU2002238106A1
(en)
*
|
2001-02-13 |
2002-08-28 |
Palatin Technologies, Inc. |
Melanocortin metallopeptides for treatment of sexual dysfunction
|
|
US20020131953A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Ut Southwestern Medical Center |
In situ langerhans cell vaccine
|
|
CN1306956C
(zh)
*
|
2001-04-17 |
2007-03-28 |
希龙公司 |
诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
CA2482747C
(en)
*
|
2002-04-19 |
2010-06-29 |
Yonsei University |
Vaccine composition for preventing meningococcal disease
|
|
EP1411061A1
(en)
*
|
2002-10-16 |
2004-04-21 |
Centre National De La Recherche Scientifique (Cnrs) |
Poly-alpha2,8-sialic acid mimetic peptides and their application
|
|
MXPA05014015A
(es)
*
|
2003-06-23 |
2006-03-17 |
Baxter Int |
Vacunas contra grupo y nisseria meningitidis y combinaciones meningococales del mismo.
|
|
CN1985000B
(zh)
*
|
2004-05-11 |
2012-05-30 |
艾比吉诺米克斯合作公司 |
诱导t细胞死亡的表位
|
|
US8148335B2
(en)
*
|
2004-06-23 |
2012-04-03 |
Children's Hospital & Research Center Oakland |
De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
|
|
US7595307B2
(en)
*
|
2004-06-23 |
2009-09-29 |
Children's Hospital And Research Center At Oakland |
Polysaccharide derivatives and uses in induction of an immune response
|
|
US8052971B2
(en)
*
|
2005-11-21 |
2011-11-08 |
MG Biologics |
Oral use of specific antibodies for intestinal health
|
|
US20080090760A2
(en)
*
|
2005-12-09 |
2008-04-17 |
Todd Hembrough |
Compositions and Methods for Inhibiting Cellular Proliferation
|
|
MX2008008185A
(es)
*
|
2005-12-23 |
2008-11-14 |
Childrens Hosp & Res Ct Oak |
Antigenos de acido des-n-acetil-sialico, anticuerpos para los mismos, y metodos de uso en la terapia de cancer.
|
|
AR058736A1
(es)
*
|
2005-12-29 |
2008-02-20 |
Ct Ingenieria Genetica Biotech |
Peptidos mimeticos de carbohidratos y su empleo en formulaciones farmaceuticas
|
|
WO2007084856A2
(en)
*
|
2006-01-13 |
2007-07-26 |
Baxter International Inc. |
Method for purifying polysaccharides
|
|
GB0606155D0
(en)
*
|
2006-03-28 |
2006-05-10 |
Liverpool School Of Tropical M |
Bacterial vaccine
|
|
WO2007116409A2
(en)
*
|
2006-04-11 |
2007-10-18 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved vaccines comprising multimeric hsp60 peptide carriers
|
|
GB0611914D0
(en)
*
|
2006-06-15 |
2006-07-26 |
Teti Giuseppe |
Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
EP2170391B1
(en)
*
|
2007-06-20 |
2017-01-18 |
Pfizer Ireland Pharmaceuticals |
Modified polysaccharides for conjugate vaccines
|
|
EP2173759A4
(en)
|
2007-07-03 |
2014-01-29 |
Childrens Hosp & Res Ct Oak |
OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE
|
|
JP5523313B2
(ja)
*
|
2007-07-03 |
2014-06-18 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
|
|
CA2692419C
(en)
*
|
2007-07-03 |
2017-12-05 |
Children's Hospital & Research Center At Oakland |
Inhibitors of polysialic acid de-n-acetylase and methods for using the same
|
|
US8067730B2
(en)
|
2007-07-20 |
2011-11-29 |
The George Washington University |
Laser ablation electrospray ionization (LAESI) for atmospheric pressure, In vivo, and imaging mass spectrometry
|
|
US20100285446A1
(en)
*
|
2007-07-20 |
2010-11-11 |
Akos Vertes |
Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
|
|
US7960336B2
(en)
*
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US20090156459A1
(en)
*
|
2007-11-16 |
2009-06-18 |
Pharmain Corporation |
Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
EP2288733A4
(en)
*
|
2008-03-18 |
2012-03-21 |
Merck Sharp & Dohme |
PROTEIN CHANGE TEST WITH HIGH THROUGHPUT
|
|
AR077636A1
(es)
*
|
2009-07-08 |
2011-09-14 |
Abbott Biologicals Bv |
Vacuna viral y uso de la misma
|
|
KR101594228B1
(ko)
|
2010-08-23 |
2016-02-15 |
와이어쓰 엘엘씨 |
네이세리아 메닌기티디스 ｒＬＰ２０８６ 항원의 안정한 제제
|
|
NZ607224A
(en)
|
2010-09-10 |
2014-11-28 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
WO2012054879A1
(en)
*
|
2010-10-22 |
2012-04-26 |
Duke University |
Compositions and methods for the treatment of septic arthritis, osteomyelitis, and bacteremia
|
|
US8829426B2
(en)
|
2011-07-14 |
2014-09-09 |
The George Washington University |
Plume collimation for laser ablation electrospray ionization mass spectrometry
|
|
JP2015517089A
(ja)
*
|
2012-03-08 |
2015-06-18 |
ノバルティス アーゲー |
タンパク質ベースの髄膜炎菌ワクチンのためのインビトロ有効性アッセイ
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MX359256B
(es)
|
2012-03-09 |
2018-09-19 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
WO2014179714A1
(en)
*
|
2013-05-03 |
2014-11-06 |
The Board Of Regents Of The University Of Texas System |
Generating peptoid vaccines
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
AU2016221318B2
(en)
|
2015-02-19 |
2020-06-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
EP4034157A1
(en)
|
2019-09-27 |
2022-08-03 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
AU2021275127A1
(en)
*
|
2020-05-19 |
2023-02-02 |
Laboratory Corporation Of America Holdings |
Methods and systems for quantitative detection of antibodies
|